3692:HKG
Hansoh Pharmaceutical Group Company Ltd
HK$ 31,74
arrow_upward
+1,15%(+0,36) 1D
16 okt, 16:08:14 GMT+8 · HKD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor 3692 genereren…
Openen
HK$ 31,72
Hoog
HK$ 32,44
Laag
HK$ 31,52
Beursw.
192,48 mld.
Gem. vol.
8,58 mln.
Volume
10,50 mln.
Dividend
1,53%
Kwartaaldividend
HK$ 0,12
Ex-dividenddatum
22 sep 2026
Koers/winst-verhouding
24,51
52 wk hoog
HK$ 44,22
52 wk laag
HK$ 28,06
WPA
HK$ 1,30
Aantal medewerkers
10K
Openen
HK$ 31,72
Hoog
HK$ 32,44
Laag
HK$ 31,52
Beursw.
192,48 mld.
Gem. vol.
8,58 mln.
Volume
10,50 mln.
Dividend
1,53%
Kwartaaldividend
HK$ 0,12
Ex-dividenddatum
22 sep 2026
Koers/winst-verhouding
24,51
52 wk hoog
HK$ 44,22
52 wk laag
HK$ 28,06
WPA
HK$ 1,30
Aantal medewerkers
10K
Nieuwsartikelen
Van webbronnen en nieuwspartners
ad-hoc-news.de
·
3 uur geleden
Hansoh Pharma stock gets HKD 47.82 consensus target
Simply Wall Street
·
3 uur geleden
Could EMA Review Alter The Investment Case For Hansoh Pharma Stock (SEHK:3692)?
Profiel
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
Over Hansoh Pharmaceutical Group Company Ltd